The total return over the past 12 months is +144.21% vs. +16.94% for the S&P 500. So far it's up +90.73% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +144.21% | +17.21% | (6.85%) | N/A | N/A | N/A |
| Total Return CAGR | +144.21% | +22.07% | +0.05% | N/A | N/A | N/A |
| Revenue CAGR | +15.46% | (5.92%) | +5.39% | +35.62% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Fortress Biotech, Inc. (FBIOP)
| Year | Start price | End price | FBIOP Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $9.49 | $18.10 | +90.73% | +14.51% | +76.22% |
| 2025 | $6.65 | $9.49 | +42.71% | +17.72% | +24.99% |
| 2024 | $11.87 | $6.65 | (39.72%) | +24.89% | (64.61%) |
| 2023 | $17.65 | $11.87 | (21.86%) | +26.19% | (48.05%) |
| 2022 | $25.88 | $17.65 | (23.74%) | (18.17%) | (5.57%) |
| 2021 | $19.39 | $25.88 | +46.67% | +28.74% | +17.93% |
| 2020 | $20.48 | $19.39 | +7.45% | +18.37% | (10.92%) |
| 2019 | $14.39 | $20.48 | +59.49% | +31.22% | +28.27% |
| 2018 | $22.75 | $14.39 | (28.77%) | (4.56%) | (24.21%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
